美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

邁克德莫特國際

0.7032

0.0000

成交量：- -

成交額：- -

市值：1.28億

市盈率：-0.03

高：0.7032

開：0.7032

低：0.7032

收：0.7032

資料載入中...

總覽公司新聞公告

印尼數字經濟崛起——電商、網約車、外賣和數字金融

华尔街见闻

天益醫療(301097.SZ)取得歐盟MDR認證證書

維力醫療(603309.SH):精密尿袋等產品獲得歐盟MDR認證

騰盛博藥發佈最新戰略性臨牀開發進展

開立醫療(300633.SZ)：“胸腹腔內窺鏡”等產品獲歐盟CE(MDR)認證

開立醫療(300633.SZ)：“S90 Exp系列超聲彩色多普勒診斷系統”已獲歐盟CE(MDR)認證

騰盛博藥在2022年美國感染性疾病周（IDWeek 2022）上公佈積極臨牀數據，以支持當前新型HIV治療候選藥物的持續開發

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MDR/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDR\",,,,,undefined,":{"symbol":"MDR","market":"US","secType":"STK","nameCN":"邁克德莫特國際","latestPrice":0.7032,"timestamp":1579294800000,"preClose":0.7032,"halted":3,"volume":0,"delay":0,"floatShares":179823187,"shares":181824089,"eps":-26.992088,"marketStatus":"停牌","change":0,"latestTime":"07-22 18:02:37 EDT","open":0.7032,"high":0.7032,"low":0.7032,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.992088,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1753228800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":0.7032,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDR\",,,,,undefined,":{"symbol":"MDR","floatShares":179823187,"roa":"-1.65%","roe":"-385.36%","lyrEps":-17.94,"shares":181824089,"dividePrice":0,"high":0.7032,"amplitude":0,"preClose":0.7032,"low":0.7032,"week52Low":0.53,"pbRate":"0.24","week52High":10.99,"institutionHeld":0.2633,"latestPrice":0.7032,"eps":-26.992088,"divideRate":0,"volume":0,"delay":0,"ttmEps":-26.992088,"open":0.7032,"prevYearClose":0.6766},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2309518551","title":"印尼數字經濟崛起——電商、網約車、外賣和數字金融","url":"https://stock-news.laohu8.com/highlight/detail?id=2309518551","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2309518551?lang=zh_tw&edition=fundamental","pubTime":"2023-02-08 19:23","pubTimestamp":1675855432,"startTime":"0","endTime":"0","summary":"中金公司认为，印尼及其数字经济具有长期发展前景，主要受益于当地中产阶级崛起、高速数字化和具有弹性的经济增长能力，预计印尼数字经济规模2026年有望达到1108亿美元，复合年增长率13%。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/ee6c891f-64bb-4673-a927-b1f919ce81dc.jpeg?imageView2/1/w/340/h/340","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/ee6c891f-64bb-4673-a927-b1f919ce81dc.jpeg?imageView2/1/w/340/h/340"],"rights":{"source":"wallstreetcn_api","url":"https://wallstreetcn.com/articles/3681476","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3681476","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_api","symbols":["LU0234572021.USD","LU0238689110.USD","BK4587","LU0109392836.USD","BK4566","IE00BJJMRX11.SGD","LU0642271901.SGD","LU1803068979.SGD","LU0786609619.USD","IE00BJJMRY28.SGD","LU0127658192.USD","IE0004445015.USD","BK4527","LU0234570918.USD","LU0861579265.USD","IE00B3S45H60.SGD","BK4514","IE00BFSS7M15.SGD","MDR","BK4550","BK4581","LU2087621335.USD","GRAB","BK4022","CPI","IE00BWXC8680.SGD",".IXIC","BK4585","BK4533","LU0456855351.SGD","LU2237443382.USD","LU1914381329.SGD","SG9999014906.USD","LU2237443549.SGD","LU0079474960.USD","BK4579","SGXZ31699556.SGD","SG9999017495.SGD","IE00B1XK9C88.USD","SG9999014880.SGD","IE0004445239.USD","SG9999014898.SGD","LU0889565833.HKD","SG9999001077.SGD","BK4507","BK4553","SG9999014914.USD","LU1316542783.SGD","IE00B1BXHZ80.USD","BK4122"],"gpt_icon":0},{"id":"2302858701","title":"天益醫療(301097.SZ)取得歐盟MDR認證證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2302858701","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2302858701?lang=zh_tw&edition=fundamental","pubTime":"2023-01-12 12:01","pubTimestamp":1673496106,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天益医疗(301097.SZ)公告，公司近日收到欧盟医疗器械法规(简称“MDR”)认证证书，相关认证产品为：Extracorporeal Blood Tubing Set(体外循环血路)、Oral/Enteral Syringe(喂食注射器)、Oral/Enteral Syringe with ENFit connector(带 ENFit 接头的喂食注射器)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/860834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDR","BK0251","301097"],"gpt_icon":0},{"id":"2302672670","title":"維力醫療(603309.SH):精密尿袋等產品獲得歐盟MDR認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2302672670","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2302672670?lang=zh_tw&edition=fundamental","pubTime":"2023-01-09 16:19","pubTimestamp":1673252394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维力医疗(603309.SH)发布公告，公司于近日收到欧盟医疗器械法规(简称“MDR”)认证证书，认证产品：Urine Meter精密尿袋(I类灭菌带测量)、Prefilled syringe with purified water or glycerin solution预灌装注射器(I类灭菌)、Empty syringe空注射器(I类灭菌)、Cap导尿塞(I类灭菌)、Spigot导尿管塞(I类灭菌)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/859011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDR","BK0251","603309"],"gpt_icon":0},{"id":"2294764247","title":"騰盛博藥發佈最新戰略性臨牀開發進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2294764247","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2294764247?lang=zh_tw&edition=fundamental","pubTime":"2022-12-27 20:00","pubTimestamp":1672142400,"startTime":"0","endTime":"0","summary":"9月，腾盛博药宣布了其BRII-296新药1期研究的积极顶线结果。腾盛博药最近收到通知，美国FDA已解除针对公司BRII-732的1期研究的临床试验暂停，以开展BRII-732每周一次较低口服剂量的研究。关于腾盛博药 腾盛博药是一家生物技术公司，致力于针对存在巨大未被满足的患者需求、治疗手段有限，以及给患者带来严重社会耻感的世界最常见的疾病开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3973804_ZH73804_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["IND","MAC","PPD","BK4561","BK1161","NRTI","BK1587","BK4551","PK","BK4530","MDR","BK1574","BK4121","02137","BK4181","BK4080"],"gpt_icon":0},{"id":"2292821948","title":"開立醫療(300633.SZ)：“胸腹腔內窺鏡”等產品獲歐盟CE(MDR)認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2292821948","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2292821948?lang=zh_tw&edition=fundamental","pubTime":"2022-12-19 20:59","pubTimestamp":1671454783,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开立医疗(300633.SZ)发布公告，公司的胸腹腔内窥镜、医用内窥镜图像处理装置、电子上消化道内窥镜和电子下消化道内窥镜已获欧盟CE(MDR)认证，批准日期为：2022年12月16日，CE证书编号:HZ2027206-1，有效期至：2027年07月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/849868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300633","CE","BK0251","BK4585","MDR","BK4109"],"gpt_icon":0},{"id":"2292582195","title":"開立醫療(300633.SZ)：“S90 Exp系列超聲彩色多普勒診斷系統”已獲歐盟CE(MDR)認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2292582195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2292582195?lang=zh_tw&edition=fundamental","pubTime":"2022-12-19 20:56","pubTimestamp":1671454595,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开立医疗(300633.SZ)发布公告，公司的S90 Exp系列超声彩色多普勒诊断系统已获欧盟CE(MDR)认证，批准日期为：2022年12月16日，CE证书编号：HZ 2027206-1，有效期至：2027年07月29日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/849864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","MDR","BK4109","300633","BK4585","CE"],"gpt_icon":0},{"id":"2276022241","title":"騰盛博藥在2022年美國感染性疾病周（IDWeek 2022）上公佈積極臨牀數據，以支持當前新型HIV治療候選藥物的持續開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2276022241","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2276022241?lang=zh_tw&edition=fundamental","pubTime":"2022-10-19 20:00","pubTimestamp":1666180800,"startTime":"0","endTime":"0","summary":"这些发现表明，BRII-732和BRII-778有望成为一种安全、耐受性良好的新型患者治疗方案，有助于减轻患者日常的用药负担，甚至还会改善许多HIV感染者目前面临的社会歧视现象。此外，腾盛博药的3个战略开发合作伙伴在IDWeek 2022上公布的16篇摘要，展示了与腾盛博药共同开发的感染性疾病项目。目前针对HIV的口服治疗方案仅限于终身每日给药，许多HIV感染者认为这种给药方式存在问题，并已严重影响到日常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3907952_ZH07952_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["MDR","PK","BK1587","BK1161","02137","BK4181","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-04-27","symbol":"MDR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1587960000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-02-24","symbol":"MDR","fiscalQuarterEnding":null,"expectedEps":0.73,"name":null,"time":"盤前","type":"earning","dateTimestamp":1582520400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-11-05","symbol":"MDR","fiscalQuarterEnding":"2019/09","expectedEps":-0.21,"name":null,"time":"","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"","actualEps":0.2},{"date":"2019-07-29","symbol":"MDR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":0.08,"defaultRemindTime":1564430400000,"name":null,"time":"盤後","dateTimestamp":1564372800000,"actualEps":0.29},{"market":"US","date":"2019-04-29","symbol":"MDR","fiscalQuarterEnding":"2019/03","expectedEps":0.09,"name":null,"time":"盤前","type":"earning","dateTimestamp":1556510400000,"reportTimeType":"pre","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDR\",market:\"US\",delay:false,,,undefined,":{}}}